Business
Psychedelic biotech Psylo raises first funds – The Australian Financial Review
Startmate company Psylo is the latest company to attract funding for its pre-clinical psychedelic research.
The space is also attracting big investment dollars in the US, UK and Europe, with Beckley Psytech raising $US80 million in August, Atai Life Sciences raising $225 million for a NASDAQ listing in 2020 and new Chicago-based venture capital group Palo Santo…
Continue Reading
-
General24 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News23 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News23 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business23 hours agoLessons from Warren Buffett’s ‘acts of omission’